Treatment of anogenital warts
RD Maw - Dermatologic clinics, 1998 - Elsevier
Infection with genital human papillomavirus (HPV) types is ubiquitous, affecting 20% to 50%
people aged 15 to 25 years, 41 with a lifetime acquisition rate in the order of 60% to 80%. 34 …
people aged 15 to 25 years, 41 with a lifetime acquisition rate in the order of 60% to 80%. 34 …
TREATMENT OF ANOGENITAL WARTS
RD Maw - Dermatologic Clinics, 1998 - derm.theclinics.com
Infection with genital human papillomavirus (HPV) types is ubiquitous, affecting 20% to 50%
people aged 15 to 25 years, 41 with a lifetime acquisition rate in the order of 60% to 80%. 34 …
people aged 15 to 25 years, 41 with a lifetime acquisition rate in the order of 60% to 80%. 34 …
Treatment of anogenital warts
RD Maw - Dermatologic clinics, 1998 - pubmed.ncbi.nlm.nih.gov
The treatment of anogenital warts has long been unsatisfactory, with high treatment failure
rates and relapse rates. It would seem that a good cell-mediated immune response is …
rates and relapse rates. It would seem that a good cell-mediated immune response is …
[引用][C] Treatment of anogenital warts: Sexually transmitted diseases
RD MAW - Dermatologic clinics, 1998 - pascal-francis.inist.fr
Treatment of anogenital warts : Sexually transmitted diseases CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Treatment of anogenital warts.
RD Maw - Dermatologic Clinics, 1998 - europepmc.org
The treatment of anogenital warts has long been unsatisfactory, with high treatment failure
rates and relapse rates. It would seem that a good cell-mediated immune response is …
rates and relapse rates. It would seem that a good cell-mediated immune response is …